Your Cross-Border Biotech Partner
Empowering Biotech Innovation, Driving Global Growth
Company Overview
TAB BIO has a specialized business development platform that enables cross-border partnerships in biotechnology and pharmaceuticals. With a focus on strategic alignment between global innovators and Chinese biotech leaders, we provide trusted insight, curated connections, and execution support to unlock high-impact deals.
What We Do
We help clients identify, evaluate, and engage the best-fit biotech and pharma partners by offering:
- Strategic Market Research:
Tailored insights on drug classes, therapeutic targets, and R&D landscapes—across China and global markets. - Company Intelligence:
In-depth profiles including corporate structure, executive backgrounds, pipeline technologies, financial activities, and differentiation analysis. - Partner Identification & Recommendations:
Customized shortlists of top-tier companies aligned with your objectives, with clear rationale and risk-reduction measures.
Why It Matters
Whether you are licensing assets, exploring JV/co-development models, or entering new markets, TAB BIO equips you with:
- Reliable, verified intelligence (not generic databases)
- Cross-border fluency in scientific, regulatory, and business norms
- Hands-on support to avoid costly mismatches and accelerate BD outcomes
Our Advantage
TAB BIO brings a bilingual, bicultural team with proven experience in early-stage scouting, licensing execution, and investor facilitation. We operate at the intersection of innovation and opportunity, bridging the gaps between global biotech ecosystems.
TAB Bio’s Rigorous Pipeline Selection
Every therapeutic candidate showcased in our pipeline has been rigorously screened, scientifically vetted, and evaluated for development feasibility through TAB Bio’s multi‑disciplinary due‑diligence platform. Only the assets that satisfy our stringent criteria for mechanism validity, manufacturability, regulatory tractability, and commercial differentiation advance into active development.
